Clinical Trials List
2020-12-01 - 2022-03-22
Phase I
Recruiting4
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- YEN-HENG LIN Division of Radiology
- YU-CHUAN LU Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 劉詩彬 Division of Urology
- Yeong-Shiau Pu Division of Urology
- FU-JEN HSUEH Division of Hematology & Oncology
- - - Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- KO-JEN LI Division of General Internal Medicine
- CHING-CHU LU Division of Radiology
- CHUNG-HSIN CHEN Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Mo Hou Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- 沈鼎文 Division of Radiology
- Po-Jung Su Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- Yuan-Cheng Chu Division of Hematology & Oncology
- Feng-Yuan Liu Division of Nuclear Medicine
- 黃文冠 Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- 黃亮鋼 Division of Hematology & Oncology
- Jing-Ren Tseng Division of Nuclear Medicine
- 張境夫 Division of Hematology & Oncology
- 林柏宏 Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Ping Lin Division of Urology
- Tzu-Hao Huang Division of Urology
- 沈書慧 Division of Radiology
- Yen-Hwa Chang Division of Urology
- 陳威任 Division of Urology
- William Huang Division of Urology
- Chih-Chieh Lin Division of Urology
- I-Shen Huang Division of Urology
- Yi-Hsiu Huang Division of Urology
- Tzu-chun Wei Division of Urology
- Chien-Hsin Ting Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
129 participants